Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients

AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID‐19 Infection in Patients with Liver Disease

(2021) Oren K. Fix et al.   HEPATOLOGY

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

(2021) Markus Cornberg et al.   JOURNAL OF HEPATOLOGY

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients

(2021) Brian J. Boyarsky et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity

(2020) Thomas Perkmann et al.   CLINICAL CHEMISTRY

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Controlled Trial of High-Dose Intradermal Versus Standard-Dose Intramuscular Influenza Vaccine in Organ Transplant Recipients

(2013) A. Baluch et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review

(2013) Isabella Eckerle et al.   PLoS One